drugset / Trial / NCT00269763

Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

NCT00269763

Phase 3 Completed 32 enrolled Alza Corporation
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to establish the clinical utility and safety of fentanyl TTS (a transdermal patch delivering the narcotic pain reliever fentanyl) in the treatment of pain in patients with cancer.

Timeline

Start
1987-10
Primary completion
Completion
1988-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Other

Indications